Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The United States remained the priciest Metoclopramide Hydrochloride market tracked, rising just above 2.7% in Q2 2026 to near USD 157.50/KG from about USD 153.30/KG in Q1, and it was elevated chemical production costs together with steady antiemetic drug procurement that kept the market elevated. The global average climbed from close to USD 145.75/KG to near USD 150.32/KG, a gain of roughly 3.1%. As the data shows, Brent crude oil and naphtha feedstock costs surged in March following maritime chokepoint closures, a shock that touched every market tracked here, and the global average is likely to run in the USD 147 to 165/KG range through the second half of the year.
Metoclopramide Hydrochloride is a substituted benzamide derived from para-aminobenzoic acid, functioning as a dopamine antagonist and gastrointestinal stimulant. It serves as the active pharmaceutical ingredient in antiemetic medications used to prevent nausea and vomiting associated with cancer chemotherapy, and in treatments for gastroparesis and GERD-related heartburn and esophagitis. India, China, and Germany rank among the top exporters of metoclopramide injection products, supplying formulation companies across major importing markets including Pakistan and Argentina. Because this API depends on regulated production standards and controlled output levels, active pharmaceutical ingredient handling costs, quality compliance expenses, and upstream feedstock costs including Brent crude and naphtha are what really move the price from quarter to quarter.
The elevated Brent crude and naphtha feedstock costs triggered by the March maritime chokepoint disruption show some sign of persisting, which points toward continued firmness through H2 2026 across every market tracked. Steady demand from antiemetic drug formulation and hospital supply chains should keep supporting the market regardless of feedstock movements.
A further maritime chokepoint disruption, or additional shipment delays and elevated freight costs, could be what pushes prices above this forecast. A normalization of Brent crude and naphtha costs, or softer pharmaceutical formulation demand, could be what eases the market back toward the lower end instead.
| Region | 2026 Price Range (USD/KG) | Outlook |
| Global Average | 147 - 165 | Feedstock costs and steady antiemetic demand support firmness |
| United States | 155 - 172 | Elevated production costs keep the market at the top |
| Germany | 152 - 168 | Export-oriented production tracks feedstock costs closely |
| Brazil | 148 - 165 | Import-dependent supply sustains firm pricing |
| China | 128 - 142 | Large production base keeps China the most affordable |
The United States stayed the priciest market tracked, with the price moving from about USD 153.30/KG to near USD 157.50/KG, a gain of just above 2.7%. It was continued elevated chemical production costs, together with steady procurement for antiemetic drug formulations, that carried the increase.
Why did the price of Metoclopramide Hydrochloride change in Q2 2026 in United States?
The Manufacturing Index has stayed expansionary, reflecting robust pharmaceutical sector activity and increased procurement of this API, and it is this steady institutional and prescription-channel demand, combined with persistent production cost pressure, that has kept United States pricing at the top of the range.
The German price moved from about USD 152.11/KG to near USD 156.80/KG, a gain of just above 3.1%. It was firm demand from pharmaceutical formulation companies, together with elevated feedstock costs tied to broader maritime disruptions, that carried the increase.
Why did the price of Metoclopramide Hydrochloride change in Q2 2026 in Germany?
Germany ranks among the top exporters of metoclopramide injection products, and it is this export-oriented production base, combined with the same elevated Brent crude and naphtha feedstock costs affecting chemical producers globally, that has kept German pricing moving in close step with the United States this year.
The Brazilian price moved from about USD 148.11/KG to near USD 153.00/KG, a gain of just above 3.3%. It was firm demand from pharmaceutical formulation companies, together with import-dependent supply carrying higher procurement costs, that carried the increase.
Why did the price of Metoclopramide Hydrochloride change in Q2 2026 in Brazil?
Brazil depends on imports to secure approved-grade material for its antiemetic drug production, and it is this import dependence, combined with the same elevated global feedstock costs affecting every market tracked here, that has kept Brazilian pricing climbing in step with the broader market.
The Chinese price moved from about USD 129.50/KG to near USD 134.00/KG, a gain of just above 3.5%. It was continued firm demand from pharmaceutical manufacturers, together with feedstock costs tied to the broader maritime chokepoint disruption, that carried the increase.
Why did the price of Metoclopramide Hydrochloride change in Q2 2026 in China?
China's domestic pharmaceutical manufacturing base has kept demand consistently firm, and it is this steady offtake, combined with the same feedstock cost pressures affecting producers globally, that has pushed Chinese pricing gradually higher even as it remains the most affordable of the four markets tracked.
The price reached close to USD 153.30/KG in Q1 2026, a rise of just above 1.2% from Q4 2025. It was steady procurement for antiemetic formulations, together with active pharmaceutical ingredient handling and quality compliance expenses, that pushed the market higher.
Why did the price of Metoclopramide Hydrochloride change in Q1 2026 in United States?
Producers faced pressure from active pharmaceutical ingredient handling costs, quality compliance expenses, and controlled inventory planning this quarter, and it was this cost base, meeting steady demand from prescription drug manufacturing, that drove the modest United States increase.
The price reached close to USD 152.11/KG in Q1 2026, a rise of just above 4.2% from Q4 2025. It was Brent crude oil and naphtha feedstock costs surging following maritime chokepoint closures, that pushed the market higher.
Why did the price of Metoclopramide Hydrochloride change in Q1 2026 in Germany?
Brent crude oil and naphtha feedstock costs surged in March following maritime chokepoint closures, inflating production expenses across the chemical supply chain, and it was this feedstock shock, combined with severe shipment delays and elevated freight, that drove the sharp German increase this quarter.
The price reached close to USD 148.11/KG in Q1 2026, a rise of just above 3.9% from Q4 2025. It was firm demand from pharmaceutical formulation companies, together with import-dependent supply carrying higher procurement costs, that pushed the market higher.
Why did the price of Metoclopramide Hydrochloride change in Q1 2026 in Brazil?
Demand from pharmaceutical formulation companies remained firm this quarter, and import-dependent supply carried higher procurement costs, and it was buyers continuing to secure approved grade material for antiemetic drug production, supporting stronger supplier offers, that drove the Brazilian increase.
The price reached close to USD 129.50/KG in Q1 2026, a rise of just above 4.4% from Q4 2025. It was feedstock cost pressure, tied to the maritime chokepoint disruption affecting Brent crude and naphtha costs, that pushed the market higher.
Why did the price of Metoclopramide Hydrochloride change in Q1 2026 in China?
The same maritime chokepoint closures that pushed Brent crude and naphtha feedstock costs higher globally reached Chinese producers as well, and it was this cost pressure, meeting steady domestic pharmaceutical demand, that drove the Chinese increase.
This market climbed steadily across every quarter tracked here. Close to USD 130.00/KG in Q1 2025 rose to about USD 134.00/KG, near USD 138.50/KG, and close to USD 141.00/KG by Q4, before continuing to about USD 145.75/KG in Q1 2026 and near USD 150.32/KG in Q2. That is a rise of roughly 15.6% across the window, tracking regulated production costs and steady pharmaceutical demand closely.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q2 2026 | 150.32 | +3.1% | ↑ Rising |
| Q1 2026 | 145.75 | +3.5% | ↑ Rising |
| Q4 2025 | 141.00 | +1.8% | ↑ Rising |
| Q3 2025 | 138.50 | +3.4% | ↑ Rising |
| Q2 2025 | 134.00 | - | - Stable |
| Q3 2026 | In Progress | - | - In Progress |
It was steady procurement from pharmaceutical formulators and structured institutional demand within hospital supply chains, meeting regulated production standards and controlled API output levels, that drove the consistent 2025 climb. The global average opened near USD 130.00/KG in Q1 and climbed to close to USD 141.00/KG by Q4, a rise of just above 8.5% for the year, with every quarter posting a gain.
The United States price climbed from about USD 140.00/KG in Q1 2025 to near USD 151.43/KG by Q4, a rise of just above 8.2% for the year. It was steady procurement from pharmaceutical formulators and structured institutional demand within hospital supply chains, meeting regulated production standards that shaped domestic availability, that drove the sustained climb through 2025.
The German price climbed from about USD 135.00/KG in Q1 2025 to near USD 146.00/KG by Q4, a rise of just above 8.1% for the year. It was steady demand from pharmaceutical manufacturing, meeting production costs that firmed gradually through the year, that drove the climb through 2025, well before the sharper feedstock shock that followed into 2026.
The Brazilian price climbed from about USD 131.00/KG in Q1 2025 to near USD 142.50/KG by Q4, a rise of just above 8.8% for the year. It was firm demand from pharmaceutical formulation companies, meeting import-dependent supply that consistently carried higher procurement costs than domestic production would, that drove the sustained climb through 2025.
The Chinese price climbed from about USD 114.00/KG in Q1 2025 to near USD 124.08/KG by Q4, a rise of just above 8.8% for the year, the smallest absolute cost among the four markets tracked throughout. It was steady domestic pharmaceutical demand, combined with China's substantial production base, that kept the Chinese benchmark the most affordable of the four all year.
Expert Market Research: Your Source for Real-Time Metoclopramide Hydrochloride Price Intelligence
Metoclopramide Hydrochloride pricing tracks both regulated production economics and upstream chemical feedstock costs, so Expert Market Research follows active pharmaceutical ingredient handling and compliance expenses closely alongside Brent crude and naphtha feedstock costs and antiemetic drug demand cycles across the four markets covered here. This is combined with trade flow data to build the forecasts. Should the Metoclopramide Hydrochloride pricing data or procurement strategy support be needed, the team is ready to help.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
It serves as the active pharmaceutical ingredient in antiemetic medications preventing nausea and vomiting associated with cancer chemotherapy, and in treatments for gastroparesis and GERD-related heartburn and esophagitis.
As of Q2 2026, the United States averages near USD 157.50/KG, Germany about USD 156.80/KG, Brazil close to USD 153.00/KG, and China roughly USD 134.00/KG. The United States remains the priciest of the four markets tracked.
The price kept climbing, from close to USD 141.00/KG in Q4 2025 up to about USD 145.75/KG in Q1 2026, then near USD 150.32/KG in Q2, a gain of just above 3.1%. Feedstock costs from the maritime chokepoint disruption drove both quarters.
Brent crude oil and naphtha feedstock costs surged in March 2026 following maritime chokepoint closures, and since these feed into the broader chemical production chain supporting API manufacturing, the shock inflated production expenses across every market tracked, compounded by severe shipment delays and elevated freight.
The global average is likely to run in the USD 147 to 165/KG range, with feedstock costs and steady antiemetic demand continuing to support firmness through the back half of the year.
The United States carries the highest cost among tracked markets. Germany sits close behind on export-oriented production, Brazil in the middle on import dependence, and China prices lowest thanks to its large domestic production base.
This data is refreshed on a monthly basis, with real-time figures available directly from the team.
Active pharmaceutical ingredient handling and quality compliance costs sit at the core, given the regulated production standards this API requires. Upstream feedstock costs including Brent crude and naphtha, and antiemetic drug demand cycles, add further influence.
India, China, and Germany rank among the top exporters of metoclopramide injection products, with the United States and Brazil representing significant consuming markets that rely partly on imports for their pharmaceutical formulation needs.
Brent crude and naphtha feedstock cost trends are usually the earliest signal worth tracking, since maritime disruptions can move them quickly and the effect passes through to the finished API price. Watching shipment delay and freight cost reports also helps anticipate supply-driven price swings before they reach quoted prices.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.